Drug Target Review2025-01-14T08:00:59
A new study demonstrates how neurotransmitters affect brain gene expression, offering potential therapeutic insights for circadian rhythm disorders.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-08-17T14:16:00Z
Contributor Dr Rab Prinjha, Drug Target Review
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-03-08T16:29:20
Sponsored by Bio-Techne
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2023-06-20T12:34:32
Sponsored by NanoTemper Technologies
2026-03-11T14:00:00
Sponsored by Merck
Site powered by Webvision Cloud